Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KOFLER, B")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 27

  • Page / 2
Export

Selection :

  • and

ULTRADIANE PERIODIK VON EMG UND EEG EINES SPASTISCHEN KINDES = RYTHME ULTRADIEN DE L'EMG ET DE L'EEG D'UN ENFANT SPASTIQUEMEIER KOLL A; KOFLER B; FELS T et al.1978; E.E.G.-E.M.G.; DEU; DA. 1978; VOL. 9; NO 2; PP. 107-112; ABS. ENG; BIBL. 12 REF.Article

EIN RUHE-AKTIVITAETSZYKLUS DER STEREOTYPEN HANDMOTORIK EINES GEISTIG BEHINDERTEN KINDES. = UN CYCLE REPOS-ACTIVITE DE LA MOTRICITE STEREOTYPEE DE LA MAIN D'UN ENFANT ARRIERE MENTALMEIER KOLL A; FELS T; KOFLER B et al.1977; E.E.G.-E.M.G.; DTSCH.; DA. 1977; VOL. 8; NO 4; PP. 195-199; ABS. ANGL.; BIBL. 16 REF.Article

Simplified PCR set-up using a frozen preformulated mix for the detection of cytomegalovirusKOFLER, B; KLAUSEGGER, A.Diagnostic microbiology and infectious disease. 1999, Vol 34, Num 1, pp 33-35, issn 0732-8893Article

Peptide YY-2 (PYY2) and pancreatic polypeptide-2 (PPY2) : Species-specific evolution of novel members of the neuropeptide Y gene familyCOUZENS, M; LIU, M; TÜCHLER, C et al.Genomics (San Diego, Calif.). 2000, Vol 64, Num 3, pp 318-323, issn 0888-7543Article

Zusammenhänge zwischen Amplitudenreduktion ereigniskorrelierter Potentiale (CNV) und Konzentrationsleistung bei der vaskulären Demenz = Relation entre la diminution de l'amplitude des potentiels évoqués et le pouvoir de concentration dans la démence vasculaire = The relationship between amplitude reduction of event related potentials and concentration ability in vascular dementiaKOFLER, B; HARRER, G; LADURNER, G et al.Nervenarzt. 1987, Vol 58, Num 11, pp 700-704, issn 0028-2804Article

Effect of a Whole-Body Vibration Session on Knee StabilityMELNYK, M; KOFLER, B; FAIST, M et al.International journal of sports medicine. 2008, Vol 29, Num 10, pp 839-844, issn 0172-4622, 6 p.Article

Alternative solvent-free preparation methods for felodipine surface solid dispersionsKERC, J; SRCIC, S; KOFLER, B et al.Drug development and industrial pharmacy. 1998, Vol 24, Num 4, pp 359-363, issn 0363-9045Article

A human ubiquitin-conjugating enzyme homologous to yeast UBC8KAISER, P; SEUFERT, W; HÖFFERER, L et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 12, pp 8797-8802, issn 0021-9258Article

Otoneurologische Befunde bei der Multiplen Sklerose: Stapediusreflex, Vestibularisprüfung, frühe akustisch evozierte Potentiale = Signes otoneurologiques dans la sclérose en plaques: réflexe stapidien, exploration vestibulaire, potentiels évoqués acoustiques précoces = Otoneurological signs in multiple sclerosis: stapedial reflex, vestibulometry, early auditory evoked potentialsOBERASCHER, G; KOFLER, B; POMMER, B et al.HNO. Hals-, Nasen-, Ohrenärzte. 1985, Vol 33, Num 1, pp 23-24, issn 0017-6192Article

Brain-stem involvement in multiple sclerosis: a comparison between brain-stem auditory evoked potentials and the acoustic stapedius reflexKOFLER, B; OBERASCHER, G; POMMER, B et al.Journal of neurology. 1984, Vol 231, Num 3, pp 145-147, issn 0340-5354Article

The neuropeptide galanin is a novel inhibitor of human hair growthHOLUB, B. S; KLOEPPER, J. E; TOTH, B. I et al.British journal of dermatology (1951). 2012, Vol 167, Num 1, pp 10-16, issn 0007-0963, 7 p.Article

Preparation and evaluation of auranofin solvent deposits onto lactoseKERC, J; SRCIC, S; MOHAR, M et al.Acta pharmaceutica (Zagreb). 1996, Vol 46, Num 2, pp 125-130, issn 1330-0075Article

Assignment of the gene encoding human galanin receptor (GALNR) to 18q23 by in situ hybridizationNICHOLL, J; KOFLER, B; SUTHERLAND, G. R et al.Genomics (San Diego, Calif.). 1995, Vol 30, Num 3, pp 629-630, issn 0888-7543Article

Dissolution study of felodipine solid dispersionsKERC, J; MOHAR, M; SRCIC, S et al.Acta pharmaceutica (Zagreb). 1993, Vol 43, Num 2, pp 113-120, issn 1330-0075Article

Gram type-specific broad-range PCR amplification for rapid detection of 62 pathogenic bacteriaKLAUSEGGER, A; HELL, M; BERGER, A et al.Journal of clinical microbiology (Print). 1999, Vol 37, Num 2, pp 464-466, issn 0095-1137Article

Formulation of dispersible nabumetone tabletsKREMZAR, L; MOHAR, M; FERCEJ-TEMELJOTOV, D et al.Acta pharmaceutica (Zagreb). 1998, Vol 48, Num 3, pp 187-192, issn 1330-0075Article

Structural organization of the mouse and human GALR1 galanin receptor genes (Galnr and GALNR) and chromosomal localization of the mouse geneJACOBY, A. S; WEBB, G. C; LIU, M. L et al.Genomics (San Diego, Calif.). 1997, Vol 45, Num 3, pp 496-508, issn 0888-7543Article

Purification and characterization of NAD+:ADP-ribosyltransferase (polymerizing) from dictyostelium discoideumKOFLER, B; WALLRAFF, E; HERZOG, H et al.Biochemical journal (London. 1984). 1993, Vol 293, pp 275-281, issn 0264-6021, 1Article

Molar solubility of felodipine in different aqueous systemKERC, J; SRCIC, S; KOFLER, B et al.International journal of pharmaceutics. 1992, Vol 81, Num 1, pp R1-R4, issn 0378-5173Article

A multidimensional approach in testing nootropic drug effects (Cerebrolysin)KOFLER, B; ERHART, C; ERHART, P et al.Archives of gerontology and geriatrics. 1990, Vol 10, Num 2, pp 129-140, issn 0167-4943Article

Lack of complex I is associated with oncocytic thyroid tumoursZIMMERMANN, F. A; MAYR, J. A; NEUREITER, D et al.British journal of cancer. 2009, Vol 100, Num 9, pp 1434-1437, issn 0007-0920, 4 p.Article

Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolismMEIERHOFER, D; MAYR, J. A; FINK, K et al.British journal of cancer. 2006, Vol 94, Num 2, pp 268-274, issn 0007-0920, 7 p.Article

Solubilization and dissolution enhancement for sparingly soluble fenofibrateTEMELJOTOV, D. F; MOHAR, M; KOFLER, B et al.Acta pharmaceutica (Zagreb). 1996, Vol 46, Num 2, pp 131-136, issn 1330-0075Article

Investigatioon of felodipine polymorphism and its glassy stateSRCIC, S; KERC, J; URLEB, U et al.International journal of pharmaceutics. 1992, Vol 87, Num 1-3, pp 1-10, issn 0378-5173Article

Die Brauchbarkeit der ereigniskorrelierten Negativität zum Nachweis therapeutischer Wirkungen von Nootropika am Beispiel von Cerebrolysin® = Contingent negative variation ― a useful EEG-index of nootropic drug efficacy (Cerebrolysin®)KOFLER, B; ERHART, C; ERHART, P et al.EEG-EMG. 1990, Vol 21, Num 3, pp 145-149, issn 0012-7590, 5 p.Article

  • Page / 2